Joseph E Wedekind

USPTO Granted Patents = 5 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

5 out of 973

University of Rochester

patents

2 out of 470

Colorado State University Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2012-2021

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11186614 - Anti-HIV peptides (2021-11-30),

2. 10538556 - Anti-HIV peptides (2020-01-21),

3. 9212205 - Nucleic acid binding compounds and methods of use (2015-12-15),

4. 8999317 - Methods and compositions related to the structure and function of APOBEC3G (2015-04-07),

5. 8158770 - Content dependent inhibitors of cytidine deaminases and uses thereof (2012-04-17),

Title: Joseph E Wedekind: Innovator in Anti-HIV Peptides

Introduction

Joseph E Wedekind is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biomedical research, particularly in the development of anti-HIV peptides. With a total of 5 patents, his work has the potential to impact the treatment of HIV.

Latest Patents

Among his latest patents, Wedekind has developed simple β-hairpin peptides in both linear and cyclic forms that specifically bind to the HIV-1 Trans-Activation Response element (HIV-1 TAR). These innovations include compositions and their uses, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Joseph E Wedekind has worked with esteemed institutions such as the University of Rochester and the Colorado State University Research Foundation. His research has been pivotal in exploring new avenues for HIV treatment.

Collaborations

He has collaborated with notable colleagues, including Brian R McNaughton and Harold C Smith, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Joseph E Wedekind's contributions to the field of anti-HIV research exemplify the importance of innovation in addressing global health challenges. His work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.